Laura Demingbook recommendations

Laura has worked in the Kenyon, Guarente, Weiss and Firestein labs on a number of topics, including aging and synthetic biology. In 2011, she started Longevity Fund, the first VC firm dedicated to funding high-potential longevity companies. So far, Longevity Fund has raised $26M and have backed Unity Biotechnology, Precision Biosciences, Metacrine, Navitor, and Alexo Therapeutics.